Artemis to Provide Biovitrum with RNAi-modified Transgenic Mice | GenomeWeb

NEW YORK, July 7 (GenomeWeb News) - Artemis Pharmaceuticals will provide Biovitrum with RNAi-modified transgenic mice, the companies said today.


Under the agreement, Cologne, Germany-based Artemis will create shRNAi knock-down transgenic mice for Biovitrum of Stockholm, Sweden.


Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

After a study finds DNA from antibiotic-resistant bacteria in Beijing smog, residents there worry, according to the New York Times.

Canada begins its search for a chief government science advisor, Nature News reports.

A company is using facial recognition tools to identify genetic disorders from pictures, Technology Review reports.

In PNAS this week: genes involved in histone deacetylation in Arabidopsis, effects of pathogenic presenilin-1 mutations, and more.